Home / Biotechnology / Bacterioph

Bacteriophage Market By Product (Phage Probiotics, Phage Therapeutics) By Route of Administration (Oral, Topical, Others) By Application (Gastroenterology, Respiratory Infection Treatment, Skin Infection Treatment, Wound Prophylaxis, Urogenital Infection Treatment, Others) By Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies) - Growth, Future Prospects & Competitive Analysis, 2016 – 2028

How will an Increase in Anti-Biotic Resistance Infection Supports Market Growth?

According to CDC, approximately 2.8 million antibiotic-resistant infections occur in the US and approximately 35,000 patients die as a result of antibiotic-resistant infections. Antibiotics are becoming increasingly ineffective as antibiotic resistance spreads over the world, resulting in more difficult-to-cure illnesses and fatalities. New antibacterial medicines, for example, are required to combat carbapenem-resistant gram-negative infectious illnesses, which the World Health Organization has designated as a concern pathogen. Multidrug-resistant bacteria can be fought and killed by biological entities with the help of Bacteriophages. When all other antibiotics fail to treat an infection, phages can eradicate the bacteria that is causing the infection, allowing medical professionals to preserve life.  The increased prevalence of antibiotic-resistant infections, as well as the development of multidrug-resistant microorganisms, are driving the growth of the Bacteriophages Therapy Market. Thus with the rising prevalence of antibiotic resistance infection, the demand for Bacteriophages will increase

bacteriophage-market

What is the Market Size of the Bacteriophage Market in terms of value?

Global Bacteriophage Market is projected to increase at a significant CAGR of 3.5 % in the coming years. In 2021, the global Bacteriophage Market was valued at USD 1,172.5 Million and is projected to reach at value of USD 1,441.3 million by 2028. The demand for Bacteriophage is projected to increase substantially in the coming years and is presumed to generate revenue opportunity for the key industry players that worth USD 268.8 million during the forecast period between 2022 and 2028.

How will the use of Phage Probiotics Benefit the Market?

Bacteriophage probiotics are gaining popularity all over the world. The development of phage probiotics offers a better alternative to traditional probiotic supplements. Bacteriophage probiotics aid in the improvement of intestinal health. The use of bacteriophages in gastroenterology has significantly grown because of these benefits. The human gastrointestinal (Gl) tract is inhabited by a diverse array of bacteria. Several variables, including nutrition and antibiotic therapy, can affect the beneficial bacterial flora of the gut, resulting in a variety of chronic and degenerative disorders in children and the elderly. Phage probiotics are so being developed to boost gastrointestinal health. 

Interesting Facts about Bacteriophage Industry

  • The Bacteriophage market is predicted to increase at a substantial rate due to rising antibiotic resistance infection manufacturing, rising research efforts for therapy development, and rising adoption of growth methods like acquisitions and collaborations by industry participants.
  • The bacteriophage therapy market will face challenges due to a lack of healthcare infrastructure in developing economies and a stringent regulatory environment.
  • In terms of market share and revenue, North America dominates the bacteriophages therapy market and will maintain its dominance throughout the projection period.
  • In terms of product, the phage probiotics sector held around 95.5 percent of the market in 2021. This product's popularity stems from its ability to improve gut flora diversity and promote the growth of beneficial bacteria.
  • The oral mode of administration benefits the most, accounting for a major share of revenue over the forecast period. This is the recommended method of administration because it is self-administrable, non-invasive, and cost-effective.

Who are the Top 10 players/companies in the Bacteriophage Market in terms of value and volume?

The key players in the global Bacteriophage Market in terms of value and volume are Eliava Biopreparations Ltd., Pherecydes Pharma, Armata Pharmaceuticals, Inc., Phagelux, Inc., Nextbiotics, InnoPhage, Ltd, Locus Biosciences, Inc., TechnoPhage, Eligo Bioscience SA, Phagomed Biopharma GmbH., PhagePro, Inc., Intralytix, Inc., Adaptive Phage Therapeutics, Enbiotix, Inc., Intodeworld, Inc., BiomX Ltd., Fixed-phage Ltd., Micreos BV, ContraFect Corporation, Phi Therapeutics, and OPTIPHARM Co., Ltd. The key players are working on different strategies such as product launch, acquisitions, partnerships, collaborations, and others to enhance their market presence.

Who are the Top 10 Countries in the Bacteriophage Market?

In the global Bacteriophage Market, the major countries are US, Canada, China, India, Japan, Australia, Germany, UK, France, and Israel. The United States leads the bacteriophages market in North America during the projected period. The increased prevalence of antibiotic resistance and rising demand for antibiotic alternatives in the country are driving market growth. The bacteriophages industry is expanding due to increased government funding and investment in novel approaches to treat antibiotic-resistant bacterial illnesses. Another important element assisting market expansion in the United States is the rising demand for phage probiotics as a probiotic supplement to promote gut health. Furthermore, the country's top manufacturers are eager to increase the market footprint of their key products and solutions. Many renowned manufacturers now provide improved solutions based on bacteriophage supplements for this purpose. Thus driving the growth of the market in the nation in the coming years.

Which is the Key Application Area in the Bacteriophage Market?

The key applications of the Bacteriophage Market include Gastroenterology, Respiratory Infection Treatment, Skin Infection Treatment, Wound Prophylaxis, Urogenital Infection Treatment, and Others. Gastroenterology is creating a big opportunity for Bacteriophage Probiotic Manufacturers. Gut health is becoming a major public health concern, and phage supplements fill an unmet demand by protecting the gut from harmful bacteria. As a result, the gastroenterology industry is likely to drive bacteriophage demand in the approaching years. The majority of bacteriophage supplements are intended to promote gut health. In many places, the USFDA has yet to approve bacteriophages as a therapy option for certain antibiotic-resistant diseases. As a result, only phage probiotics are currently used by various professionals to improve and treat gut health issues.

What are the Major Driving Factors for Bacteriophage Market?

The increase in the prevalence rate of foodborne infections around the world will be a primary driver of the market's growth rate. Another key element affecting the growth rate of the bacteriophages therapy market is rising healthcare expenditure, which aids in infrastructure improvement. Furthermore, numerous government organizations intend to improve healthcare infrastructure by boosting financing, which would have an impact on market dynamics. Antimicrobial-resistant infections are becoming more common, resulting in greater healthcare spending and an increase in the number of deaths. The increasing occurrence of antibiotic-resistant illnesses is likely to boost market growth. Furthermore, an increasing number of government measures to raise awareness and increase in the aging population would result in the bacteriophage therapy market expanding. Along with this, people's changing lifestyles and rising levels of disposable money would boost the market's growth rate.

What are the Major Restraints for Bacteriophage Market?

The high cost of bacteriophages therapy would impede the growth rate of the bacteriophages therapy market during the forecast period. The bacteriophage therapy market will face challenges due to a lack of healthcare infrastructure in developing economies and a stringent regulatory environment. Furthermore, a lack of awareness among people and the availability of alternatives may hinder and impede the market's growth rate during the projection period.

Which Region Dominated the World Bacteriophage Market?

In terms of market share and revenue, North America dominates the bacteriophages therapy market and will maintain its dominance throughout the projection period. This is because bacteriophage provides quick recovery and therapeutic impact, and rising healthcare expenditure would further boost the market's development rate in this region. The fundamental characteristics of the North American market are a strong desire to alleviate the burden of antibiotic-resistant illnesses, a well-established research infrastructure, and the presence of a prospective pipeline for phage therapy. Furthermore, the presence of major key players and the increased acceptance of newer technologies would accelerate the market's growth rate in this area.

Asia-Pacific is predicted to be the fastest-growing region during the forecast period due to increased investment in creative R&D for novel drug products in this area Furthermore, the expansion of healthcare infrastructure and rising government efforts would accelerate the market's growth rate in this region. Rapidly growing biotechnology infrastructure, altering agricultural methods, and similarly supportive government activities all contribute to the Asia Pacific market's rapid growth.

Segmentation of Global Bacteriophage Market-

Bacteriophage Market- By Product

  • Phage Probiotics
  • Phage Therapeutics

Bacteriophage Market- By Route of Administration

  • Oral
  • Topical
  • Others

Bacteriophage Market- By Application

  • Gastroenterology
  • Respiratory Infection Treatment
  • Skin Infection Treatment
  • Wound Prophylaxis
  • Urogenital Infection Treatment
  • Others

Bacteriophage Market- By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies

The COVID-19 pandemic created major hurdles to enterprises in the global bacteriophage therapy sector. With the inconsistencies in the transportation facility, obtaining raw materials for the production of medicine formulations was a major challenge. The COVID-19 epidemic hampered clinical trials in the United States, hurting key companies throughout the industry.

North America dominates the bacteriophages therapy market and will maintain its dominance throughout the projection period. This is because bacteriophage provides quick recovery and therapeutic impact, and rising healthcare expenditure would further boost the market's development rate in this region.

The rise in the incidence of various antibiotic-resistant illnesses around the world is expected to help the worldwide bacteriophage market grow.

In terms of product, the phage probiotics sector held around 95.5 percent of the market in 2021.

Gastroenterology is creating a big opportunity for Bacteriophage Probiotic Manufacturers. Gut health is becoming a major public health concern, and phage supplements fill an unmet demand by protecting the gut from harmful bacteria.

Bacteriophage Market Scope

Report Attribute Details
Market Value in 2021 USD 1,172.5 Million
Market Value in 2028 USD 1,441.3 million
CAGR 3.5 %
Benchmarking Year 2021
Past data 2016 – 2021
Forecast period 2022 – 2028
Choose License Type
Related Report










Published Date:  Jul 2022
Category:  Biotechnology
Report ID:   59356
Report Format:   PDF
Pages:   120
Rating:    4.8 (76)
Connect With Us
+1-408-641-3282
24/7 Research Support